AMP deaminase-2- and adenosine deaminase-mediated disposal of β-cell intracellular adenosine protects against multiple low-dose streptozotocin-induced type 1 diabetesAMP脱氨酶-2和腺苷脱氨酶介导的β细胞内源性腺苷的清除可防止低剂量链脲佐菌素诱导的1型糖尿病。Biomedicine & PharmacotherapyIF7.52026-01-060OAAI
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetesENDOCRINEIF2.92024-02-291OAAI
The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumorsSCIENTIFIC REPORTSIF3.92019-05-1710OAAI
Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetesCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82019-03-2426OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向